SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-005932
Filing Date
2019-10-28
Accepted
2019-10-28 16:34:12
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a2239917zs-3.htm S-3 184998
2 EX-5.1 a2239917zex-5_1.htm EX-5.1 18658
3 EX-23.1 a2239917zex-23_1.htm EX-23.1 3038
4 G121506.JPG g121506.jpg GRAPHIC 17627
5 G207922KQI001.JPG g207922kqi001.jpg GRAPHIC 3409
6 G207922KQI002.GIF g207922kqi002.gif GRAPHIC 5769
  Complete submission text file 0001047469-19-005932.txt   245192
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234353 | Film No.: 191173376
SIC: 3841 Surgical & Medical Instruments & Apparatus